Type 2 Diabetes Trial, By Invitation NCT06895018 Sponsor: Federico II University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT06895018
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People with a Body Mass Index (BMI) over 25 and up to 35 (this is a measure of body weight relative to height that falls in the overweight to moderate obesity range).
  • People whose blood cholesterol level is 250 mg/dl or below and whose triglyceride (blood fat) level is 200 mg/dl or below.
  • People with type 2 diabetes that is well controlled (based on a blood sugar marker called HbA1c being 7.5% or below), managed through diet alone or diet combined with the medication metformin.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a heart attack or stroke.
  • People with kidney problems (indicated by a blood creatinine level above 1.5 mg/dl) or liver problems (indicated by certain liver enzyme levels being more than twice the normal range).
  • People with anaemia (low haemoglobin, below 12 g/dl) or another ongoing chronic illness.
  • People who use insulin or any blood sugar-lowering medication other than metformin.
  • People who regularly do intense physical activity.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Federico II University
Registry
ClinicalTrials.gov
Start date
3 May 2024
Est. completion
8 August 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Differences in liver fat content

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov